Generic placeholder image

Current Medicinal Chemistry


ISSN (Print): 0929-8673
ISSN (Online): 1875-533X

Colchicine Semisynthetics: Chemotherapeutics for Cancer?

Author(s): G. Sivakumar

Volume 20, Issue 7, 2013

Page: [892 - 898] Pages: 7

DOI: 10.2174/0929867311320070005

Price: $65


Nitrogen-containing bioactive alkaloids of plant origin play a significant role in human health and medicine. Several semisynthetic antimitotic alkaloids are successful in anticancer drug development. Gloriosa superba biosynthesizes substantial quantities of colchicine, a bioactive molecule for gout treatment. Colchicine also has antimitotic activity, preventing growth of cancer cells by interacting with microtubules, which could lead to the design of better cancer therapeutics. Further, several colchicine semisynthetics are less toxic than colchicine. Research is being conducted on effective, less toxic colchicine semisynthetic formulations with potential drug delivery strategies directly targeting multiple solid cancers. This article reviews the dynamic state of anticancer drug development from colchicine semisynthetics and natural colchicine production and briefly discusses colchicine biosynthesis.

Keywords: Bioreactor, cancer, colchicine, thiocolchicine dimers, Gloriosa superba, Colchicine Semisynthetics, Chemotherapeutics, bioactive alkaloids, plant origin, antimitotic alkaloids

Rights & Permissions Print Export Cite as
© 2023 Bentham Science Publishers | Privacy Policy